Gemcitabine Hydrochloride and Alvocidib in Treating Patients With Solid Tumors

NCT00072436 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

58

Enrollment

NIH

Sponsor class

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: gemcitabine hydrochloride
DRUG: alvocidib
OTHER: pharmacological study

Sponsor

National Cancer Institute (NCI)